Capstone Investment Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-3,005
Closed -$354K – 1871
2026
Q1
$354K Buy
+3,005
New +$420K ﹤0.01% 1301
2025
Q4
– Sell
-4,711
Closed -$630K – 1970
2025
Q3
$630K Buy
+4,711
New +$572K ﹤0.01% 1243
2024
Q2
– Sell
-1,831
Closed -$337K – 2399
2024
Q1
$337K Buy
+1,831
New +$349K ﹤0.01% 1772
2021
Q4
– Sell
-3,473
Closed -$1M – 2055
2021
Q3
$1M Buy
+3,473
New +$891K ﹤0.01% 1400
2017
Q4
– Sell
-13,763
Closed -$527K – 628
2017
Q3
$527K Buy
+13,763
New +$577K 0.02% 310
2017
Q1
– Sell
-7,900
Closed -$243K – 1079
2016
Q4
$243K Buy
+7,900
New +$244K 0.01% 777

Other funds holding RGEN

Capstone Investment Advisors's RGEN Position: Q2 2026 in Review

Capstone Investment Advisors sold out of Repligen (RGEN) in Q2 2026, closing a stake of 3,005 shares — an estimated $354K sold.

Capstone Investment Advisors first reported a position in RGEN in Q4 2016 and held it in 6 quarters. The position peaked at $1M in Q3 2021. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Capstone Investment Advisors reported no remaining Repligen position as of Q2 2026 after selling out during the quarter.
  • Capstone Investment Advisors sold 3,005 Repligen shares in Q2 2026, an estimated $354K.
  • Capstone Investment Advisors first reported a position in Repligen in Q4 2016 and held it in 6 quarters.
  • Capstone Investment Advisors's Repligen position peaked at $1M in Q3 2021.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Capstone Investment Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.